| Primary |
| Chronic Obstructive Pulmonary Disease |
38.1% |
| Product Used For Unknown Indication |
25.0% |
| Asthma |
6.9% |
| Bronchiectasis |
3.8% |
| Emphysema |
3.8% |
| Lung Disorder |
3.1% |
| Hypertension |
2.5% |
| Acute Respiratory Distress Syndrome |
1.9% |
| Dyspnoea |
1.9% |
| Lung Neoplasm Malignant |
1.9% |
| Pneumonia |
1.9% |
| Anticoagulant Therapy |
1.3% |
| Bronchitis Chronic |
1.3% |
| Convulsion |
1.3% |
| Pulmonary Fibrosis |
1.3% |
| Swelling |
1.3% |
| Wheezing |
1.3% |
| Alpha-1 Anti-trypsin Deficiency |
0.6% |
| Angina Pectoris |
0.6% |
| Anxiety |
0.6% |
|
| Death |
13.8% |
| Pneumonia |
12.1% |
| Tremor |
8.6% |
| Weight Decreased |
6.9% |
| Wheezing |
6.9% |
| Condition Aggravated |
5.2% |
| Dyspnoea |
5.2% |
| Vomiting |
5.2% |
| Chronic Obstructive Pulmonary Disease |
3.4% |
| Head Injury |
3.4% |
| Infection |
3.4% |
| Oedema Peripheral |
3.4% |
| Stomatitis |
3.4% |
| Treatment Noncompliance |
3.4% |
| Troponin Increased |
3.4% |
| Ventricular Fibrillation |
3.4% |
| Weight Increased |
3.4% |
| Accidental Overdose |
1.7% |
| Anxiety |
1.7% |
| Appendicitis Perforated |
1.7% |
|
| Secondary |
| Chronic Obstructive Pulmonary Disease |
39.0% |
| Emphysema |
8.5% |
| Product Used For Unknown Indication |
7.6% |
| Asthma |
7.2% |
| Dyspnoea |
7.2% |
| Cough |
6.8% |
| Pneumonia |
3.8% |
| Aspiration |
3.4% |
| Rales |
3.4% |
| Wheezing |
3.4% |
| Bronchiectasis |
1.7% |
| Cardiac Disorder |
1.3% |
| Blood Cholesterol Increased |
0.8% |
| Blood Pressure Abnormal |
0.8% |
| Drug Use For Unknown Indication |
0.8% |
| Hypersensitivity |
0.8% |
| Hypertension |
0.8% |
| Pulmonary Arterial Hypertension |
0.8% |
| Pulmonary Oedema |
0.8% |
| Respiratory Failure |
0.8% |
|
| Dyspnoea |
16.4% |
| Swollen Tongue |
11.9% |
| Heart Rate Increased |
9.0% |
| Drug Ineffective |
6.0% |
| Tremor |
6.0% |
| Chest Pain |
4.5% |
| Off Label Use |
4.5% |
| Vocal Cord Inflammation |
4.5% |
| Wrong Technique In Drug Usage Process |
4.5% |
| Chronic Obstructive Pulmonary Disease |
3.0% |
| Exercise Tolerance Decreased |
3.0% |
| Gingival Erosion |
3.0% |
| Headache |
3.0% |
| Medication Error |
3.0% |
| Oedema Peripheral |
3.0% |
| Pneumonia |
3.0% |
| Stomatitis |
3.0% |
| Swelling Face |
3.0% |
| Throat Irritation |
3.0% |
| Tobacco User |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.1% |
| Chronic Obstructive Pulmonary Disease |
18.2% |
| Drug Use For Unknown Indication |
16.7% |
| Asthma |
9.1% |
| Hypertension |
5.2% |
| Emphysema |
4.2% |
| Pulmonary Arterial Hypertension |
2.3% |
| Osteoporosis |
2.2% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Hypersensitivity |
2.1% |
| Anxiety |
1.6% |
| Pain |
1.6% |
| Crohn's Disease |
1.4% |
| Diabetes Mellitus |
1.3% |
| Blood Cholesterol Increased |
1.2% |
| Coronary Artery Disease |
1.2% |
| Supplementation Therapy |
1.2% |
| Seasonal Allergy |
1.1% |
| Cardiac Disorder |
1.1% |
| Cystic Fibrosis |
0.9% |
|
| Dyspnoea |
14.6% |
| Death |
12.4% |
| Pneumonia |
8.8% |
| Insomnia |
7.3% |
| Weight Decreased |
7.3% |
| Product Quality Issue |
5.8% |
| Tremor |
5.1% |
| Cardiac Arrest |
3.6% |
| Drug Ineffective |
3.6% |
| Oedema Peripheral |
3.6% |
| Wheezing |
3.6% |
| Blood Pressure Increased |
2.9% |
| Off Label Use |
2.9% |
| Swollen Tongue |
2.9% |
| Varices Oesophageal |
2.9% |
| Visual Impairment |
2.9% |
| Weight Increased |
2.9% |
| Clostridial Infection |
2.2% |
| Drug Dose Omission |
2.2% |
| Dry Mouth |
2.2% |
|
